|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
GEMTUZUMAB OZOGAMICIN |
L01FX02 |
PT
|
POM
|
14-11-2018 |
EMEA/H/C/004204 |
21-09-2018 |
VALID
|
|
IPILIMUMAB |
L01FX04 |
PT
|
POM
|
27-01-2022 |
|
|
VALID
|
|
BRENTUXIMAB VEDOTIN |
L01FX05 |
PT
|
POM
|
|
|
|
VALID
|
|
DINUTUXIMAB BETA |
L01FX06 |
PT
|
POM
|
|
EMEA/H/C/003918 |
08-05-2017 |
VALID
|
|
BLINATUMOMAB |
L01FX07 |
PT
|
POM
|
|
|
|
VALID
|
|
ELOTUZUMAB |
L01FX08 |
PT
|
POM
|
22-08-2017 |
EMEA/H/C/003967 |
11-05-2016 |
VALID
|
|
MOGAMULIZUMAB |
L01FX09 |
PT
|
POM
|
05-06-2020 |
EMEA/H/C/004232 |
22-11-2018 |
VALID
|
|
OLARATUMAB |
L01FX10 |
PT
|
Not authorised
|
27-01-2022 |
|
|
VALID
|
|
TAFASITAMAB |
L01FX12 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005436 |
26-08-2021 |
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
|
POLATUZUMAB VEDOTIN |
L01FX14 |
PT
|
POM
|
05-06-2020 |
EMEA/H/C/004870 |
16-01-2020 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
AMIVANTAMAB |
L01FX18 |
PT
|
POM
|
|
|
|
VALID
|
|
TREMELIMUMAB |
L01FX20 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004650 |
20-02-2023 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
ZOLBETUXIMAB |
L01FX31 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005868 |
19-09-2024 |
VALID
|
|
ELRANATAMAB |
L01FX32 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005908 |
07-12-2023 |
VALID
|
|
PERTUZUMAB AND TRASTUZUMAB |
L01FY01 |
PT
|
POM
|
|
|
|
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
CISPLATIN |
L01XA01 |
PT
|
POM
|
22-08-2017 |
PT/H/1207/001/ |
15-02-2016 |
VALID
|
|
PROCARBAZINE |
L01XB01 |
PT
|
Not subject to prescription
|
|
None |
|
DELETED
|
|
TRASTUZUMAB |
L01XC03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
CETUXIMAB |
L01XC06 |
PT
|
POM
|
|
|
|
VALID
|
|
AMINOLEVULINIC ACID |
L01XD04 |
PT
|
POM
|
22-08-2017 |
EMEA/H/C/000744 |
07-09-2007 |
VALID
|
|
PADELIPORFIN |
L01XD07 |
PT
|
POM
|
14-11-2018 |
EMEA/H/C/004182 |
15-11-2017 |
VALID
|
|
FEDRATINIB |
L01XE57 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005026 |
08-02-2021 |
VALID
|
|
TRETINOIN |
L01XF01 |
PT
|
POM
|
|
|
|
VALID
|
|
ALITRETINOIN |
L01XF02 |
PT
|
POM
|
|
|
|
VALID
|
|
BEXAROTENE |
L01XF03 |
PT
|
POM
|
|
|
|
VALID
|
|
BORTEZOMIB |
L01XG01 |
PT
|
POM
|
|
|
|
VALID
|
|
CARFILZOMIB |
L01XG02 |
PT
|
POM
|
|
|
|
VALID
|
|
IXAZOMIB |
L01XG03 |
PT
|
POM
|
22-08-2017 |
EMEA/H/C/003844 |
21-11-2016 |
VALID
|
|
PANOBINOSTAT |
L01XH03 |
PT
|
POM
|
07-04-2016 |
EMEA/H/C/003725 |
28-08-2015 |
VALID
|
|
VISMODEGIB |
L01XJ01 |
PT
|
POM
|
|
|
|
VALID
|
|
SONIDEGIB |
L01XJ02 |
PT
|
POM
|
07-04-2016 |
EMEA/H/C/002839 |
14-08-2015 |
VALID
|
|
OLAPARIB |
L01XK01 |
PT
|
POM
|
|
|
|
VALID
|
|
NIRAPARIB |
L01XK02 |
PT
|
POM
|
14-11-2018 |
EMEA/H/C/004249 |
08-01-2018 |
VALID
|
|
RUCAPARIB |
L01XK03 |
PT
|
POM
|
14-11-2018 |
EMEA/H/C/004272 |
23-08-2018 |
VALID
|
|
TALAZOPARIB |
L01XK04 |
PT
|
POM
|
|
|
|
VALID
|
|
TALIMOGENE LAHERPAREPVEC |
L01XL02 |
PT
|
POM
|
|
|
|
VALID
|
|
AXICABTAGENE CILOLEUCEL |
L01XL03 |
PT
|
POM
|
|
EMEA/H/C/004480 |
09-02-2018 |
VALID
|
|
TISAGENLECLEUCEL |
L01XL04 |
PT
|
POM
|
|
EMEA/H/C/004090 |
19-07-2018 |
VALID
|
|
CILTACABTAGENE AUTOLEUCEL |
L01XL05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005095 |
25-05-2022 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
IDECABTAGENE VICLEUCEL |
L01XX00 |
PT
|
Not authorised
|
13-10-2021 |
|
|
VALID
|
|
HYDROXYCARBAMIDE |
L01XX05 |
PT
|
POM
|
22-01-2019 |
PT/H/1081/001/ |
22-05-2014 |
VALID
|
|
PEGASPARGASE |
L01XX24 |
PT
|
POM
|
18-07-2023 |
|
|
VALID
|
